Water

Water

SCHEMBL105519

CCCCN(CCCC)CCCC.O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
THRB known ✓ P10828 1/20 0.40
MEN1 known ✓ O00255 1/20 0.37
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA9 Q16790 2/20 0.43
TSHR P16473 2/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.41
DNM1 Q05193 3/20 0.40
KDM5A P29375 3/20 0.40
PHF8 Q9UPP1 2/20 0.38
ALDH1A1 P00352 1/20 0.38
ALDH2 P05091 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL6576991 1.00 CA12 (0.43) CA12CA1CA9TSHRLMNA
Water SCHEMBL8722192 1.00 CA12 (0.43) CA12CA1CA9TSHRLMNA
Water SCHEMBL6577707 1.00 CA12 (0.43) CA12CA1CA9TSHRLMNA
Water SCHEMBL9199768 1.00 CA12 (0.43) CA12CA1CA9TSHRLMNA
Water SCHEMBL28493371 0.96 CA12 (0.42) CA12CA1CA9TSHRLMNA
Ammonia Solution, Strong SCHEMBL28204582 0.96 CA12 (0.42) CA12CA1CA9TSHRLMNA
Fluoride SCHEMBL3200626 0.96 CA12 (0.42) CA12CA1CA9TSHRLMNA
SCHEMBL3904839 0.96 TSHR (0.46) CA12CA1CA9TSHRLMNA
SCHEMBL27566038 0.96 TSHR (0.46) CA12CA1CA9TSHRLMNA
SCHEMBL896 0.96 TSHR (0.46) CA12CA1CA9TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260052827-A1 METHOD FOR PREPARING STABLE ORGANIC ELECTROCHEMICAL TRANSISTORS UNIV KENTUCKY RES FOUND (US) 2026-02-19 US claimed
CN-119430214-A Eutectic titanium silicon molecular sieve and preparation method and application thereof 中国石油化工股份有限公司 2025-02-14 CN claimed
CN-108342735-A Etching solution for tungsten and GST films 弗萨姆材料美国有限责任公司 2018-07-31 CN claimed
US-9884879-B2 Method of synthesizing siloxane monomers and use thereof SILECS OY (FI) 2018-02-06 US claimed
EP-3149140-A1 WATER CLUSTER-DOMINANT ALKALI SURFACTANT COMPOSITIONS AND THEIR USE The Procter & Gamble Company (US) 2017-04-05 EP claimed
EP-3149139-A1 WATER CLUSTER-DOMINANT ALKALI SURFACTANT COMPOSITIONS AND THEIR USE The Procter & Gamble Company (US) 2017-04-05 EP claimed
EP-3149138-A1 WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE The Procter & Gamble Company (US) 2017-04-05 EP claimed
US-20170088565-A1 Method of synthesizing siloxane monomers and use thereof SILECS OY (FI) 2017-03-30 US claimed
CN-106459841-A Water cluster-dominant boronic acid alkali surfactant compositions and their use 宝洁公司 2017-02-22 CN claimed
CN-106459837-A Water cluster dominated alkali surfactant compositions and uses thereof 宝洁公司 2017-02-22 CN claimed
US-20150344818-A1 WATER CLUSTER-DOMINANT ALKALI SURFACTANT COMPOSITIONS AND THEIR USE THE PROCTER & GAMBLE COMPANY 2015-12-03 US claimed
US-20150344819-A1 WATER CLUSTER-DOMINANT ALKALI SURFACTANT COMPOSITIONS AND THEIR USE THE PROCTER & GAMBLE COMPANY 2015-12-03 US claimed
US-20150344820-A1 COMPOSITIONS AND METHODS FOR BIOFILM TREATMENT THE PROCTER & GAMBLE COMPANY 2015-12-03 US claimed
WO-2012172176-A9 METHOD OF SYNTHESIZING SILOXANE MONOMERS AND USE THEREOF SILECS OY (FI) 2013-02-07 WO claimed
WO-2012172176-A2 METHOD OF SYNTHESIZING SILOXANE MONOMERS AND USE THEREOF SILECS OY (FI) 2012-12-20 WO claimed
CN-102009984-B Method for preparing molecular sieve from chlorosilane JIANGSU ZHONGNENG SILICON INDUSTRY TECHNOLOGY DEV CO LTD 2012-07-25 CN claimed
CN-102009984-A Method for preparing molecular sieve from chlorosilane JIANGSU ZHONGNENG POLYSILICON TECHNOLOGY DEV CO LTD 2011-04-13 CN claimed
EP-1412284-A2 COMPOSITION FOR TREATING CELLS AND METHODS FOR QUALITATIVELY AND QUANTITATIVELY CUSTOMIZING THE FORMULATION THEREOF FOR A HEURISTICALLY DERIVED LIVING CELL NUTRIENT-COMPOSITION-ON-DEMAND Runkis, Walter H. (US) 2004-04-28 EP claimed
US-20030073580-A1 Composition for treating cells and method for qualitatively and quantitatively customizing the formulation thereof RUNKIS WALTER H (US) 2003-04-17 US claimed
WO-2002100772-A2 COMPOSITION AND METHOD FOR TREATING CELLS AND PLANTS RUNKIS WALTER H (US) 2002-12-19 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260052827-A1 METHOD FOR PREPARING STABLE ORGANIC ELECTROCHEMICAL TRANSISTORS BDNF, GAP43, CNTN1 THRB 2539/4885MEN1 559/4885CA12 1253/4885
US-20170088565-A1 Method of synthesizing siloxane monomers and use thereof MSMO1, PCNA, PIEZO1 THRB 4738/4885MEN1 1913/4885CA12 3193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.